SPOTLIGHT -
Dallas-Essilor Laboratories of America has completed the required testing and is ready to provide eyewear that complies with the American National Standards Institute's new Z87.1-2003 standard when it takes effect Aug. 19.
Prior intravitreal injections may be associated with risk of postoperative cataract surgery complications
Claris Bio's journey toward treating neurotrophic keratitis
Research suggests tear fluid testing as promising method for Huntington’s Disease monitoring
(EyePod) From idea to impact: Navigating ophthalmic innovation
ARVO 2024: How a deep learning model can benefit femtosecond laser-assisted cataract surgery
ARVO 2024: AI may open new frontiers in vision research